Hong Guo

机构：Army Medical University, Chongqing University, Daping Hospital, Sanofi (United States), Gansu Provincial Maternal and Child Health Hospital, First People's Hospital of Chongqing, University of Chinese Academy of Sciences · ORCID：0000-0001-6843-4997

发表论文 57 篇 · 总被引 1177 次 · h-index 18

代表论文

• Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study (2024 · The Lancet · 被引 107)
• Association of the incidence of postherpetic neuralgia with early treatment intervention of herpes zoster and patient baseline characteristics: A systematic review and meta-analysis of cohort studies (2024 · International Journal of Infectious Diseases · 被引 24)
• Monocarboxylate Transporter 1 May Benefit Cerebral Ischemia via Facilitating Lactate Transport From Glial Cells to Neurons (2022 · Frontiers in Neurology · 被引 22)
• Celastrol Alleviates Intestinal Epithelial Permeability by Inhibiting Ferroptosis through PI3K/Akt/FOXO1/HO-1 Signaling Pathway (2025 · The American Journal of Chinese Medicine · 被引 6)
• Association of diet and outdoor time with inflammatory bowel disease: a multicenter case-control study using propensity matching analysis in China (2024 · Frontiers in Public Health · 被引 6)
• Association of Systemic Inflammatory Biomarkers (NLR, MLR, PLR, SII, SIRI) with Preeclampsia-Related Kidney Injury: A Retrospective Observational Study (2025 · Journal of Inflammation Research · 被引 5)